Potential Mechanisms of Action of Interferon-αin CML

Publisher Website
Google Scholar
Abstract
Treatment with interferon-α (IFN-α) adequately controls the leukemic cell mass in the majority of newly diagnosed patients with chronic myeloid leukemia (CML). However, the degree of response ranges from no ‘hematologic' response to complete suppression of the leukemic clone. The mechanism(s) by which IFN-α elicits these responses is unknown, but in vitro studies have indicated that IFN-α might function by (1) selective toxicity against the leukemic clone, (2) enhancement of ‘immune' regulation, and (3) modulation of bone marrow microenvironmental regulation of hematopoiesis. Using in vitro clonogenic assays we were unable to demonstrate that IFN-α selectively inhibited the proliferation of CML progenitor cells. We also found no difference in the expression of LFA-3 on normal or CML CD34+ cells. However, by panning and co-culturing hematopoietic cells on monolayers of bone marrow stromal cells, grown with and without IFN-α, we found that IFN-α enhanced the adhesion of CML progenitors to stromal cells, whereas adhesion by normal progenitor cells was essentially unaffected. This enhanced adhesion by CML progenitor cells was associated with a reduction in neuraminic acid levels in the extracellular matrix overlying stromal cells. Therefore, it is possible that one of the mechanisms by which IFN-α exerts its regulatory effect on the leukemic clone is through enhancement of hematopoietic cell-microenvironmental cell interactions.

This publication has 17 references indexed in Scilit: